- All
- 2024-09-06 [Friday]
- 2024-09-07 [Saturday]
- 2024-09-08 [Sunday]
- All
- 3rd Floor International Hall
- 3rd Floor Dubai Hall
- 3rd Floor Hong Kong Hall
- 3rd Floor London Hall
2024-09-06 Friday
3rd Floor Hong Kong Hall (UTC+8) 2024-09-06 Local Time
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
|---|---|---|---|---|
| 14:00-14:10 | 14:00-14:10 |
Is one stage mPCN is safe for kidney stones with multilocular pyonephrosis? |
Jun Da [China] | |
| 14:10-14:20 | 14:10-14:20 |
SWL in the management of paediatric stones in the era of flexible URS and mini-PNL? |
Temirov Nurali [Tajikistan] | |
| 14:20-14:30 | 14:20-14:30 |
Increase in vitamin D receptors may cause hyperoxaluria via altering hepatocellular oxalate synthesis with change of the let-7a-5p/AGXT2 signals in NAFLD |
Huan Yang [China] | |
| 14:30-14:40 | 14:30-14:40 |
Management of asymptomatic smaller stones (< 10 mm): Observation and removal in which cases and why? |
Ahmad nazran Fadzli [Malaysia] | |
| 14:40-14:50 | 14:40-14:50 |
Identification of resolvin D1 and protectin D1 as potential therapeutic agents for treating kidney stones |
Bohan Wang [China] | |
| 14:50-15:00 | 14:50-15:00 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
|---|---|---|---|---|
| 15:00-15:10 | 15:00-15:10 |
Mechanism of kidney stone formation: What is new in 2024? |
Yin Sun [USA] | |
| 15:10-15:20 | 15:10-15:20 |
Intestinal microbiota - a new perspective on the prevention and treatment of urolithiasis |
Hua Xu [China] | |
| 15:20-15:30 | 15:20-15:30 |
Nanocrystallites in urines and their relationship to urinary stones |
Jianmin Ouyang [China] | |
| 15:30-15:40 | 15:30-15:40 |
The role of the Caveolin in crystal formation |
Bing Gao [China] | |
| 16:30-16:40 | 16:30-16:40 |
Revolutionizing Medical Surgery Guided by Near Infrared-II (NIR-II) Imaging |
Haoran Liu [China] | |
| 16:40-16:50 | 16:40-16:50 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
|---|---|---|---|---|
| 16:20-16:30 | 16:20-16:30 |
Characteristics of bacteria in urine and stones from patients treated with percutaneous nephrolithotomy and association with postoperative infection |
Wenqi Wu [China] | |
| 16:30-16:40 | 16:30-16:40 |
ESWL still valid in the Era of Endouroloy |
Wael N. Ghandour [Lebanon] | |
| 16:40-16:50 | 16:40-16:50 |
Expert consensus on perioperative urosepsis nursing of patients with intracavitary surgery for urinary tract calculi |
Yan Zhao [China] | |
| 16:50-17:00 | 16:50-17:00 |
Development and new progress of extracorporeal shock wave lithotripsy in China |
Wei Zhu [China] | |
| 17:00-17:10 | 17:00-17:10 |
Suction in renal stone treatment: DISS, bendable access sheath with suction or combined procedure, update 2024 |
||
| 17:10-17:20 | 17:10-17:20 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | |
|---|---|---|---|---|
| 17:20-17:30 | 17:20-17:30 |
The role of gut microbiota in calcium oxalate kidney stones:Perspetives from western medicine to traditional Chinese one |
Songtao Xiang [China] | |
| 17:30-17:40 | 17:30-17:40 |
What are the new supportive modalities in the horizon to increase the efficacy of SWL? |
Cesar Recalde [Paraguay] | |
| 17:40-17:50 | 17:40-17:50 |
Engineered macrophage cell membrane coated disulfiram loaded MnO2 nanoparticles protected against calcium oxalate induced kidney injury |
Kun Tang [China] | |
| 17:50-18:00 | 17:50-18:00 |
Medical treatment of renal stones: indications and effectiveness |
Juan M Lopez Martinez [Spain] | |
| 18:00-18:10 | 18:00-18:10 |
Nanozyme suppresses kidney calcium oxalate crystal depositions by alleviating oxidative stress and inflammatory injury |
Yang Liu [China] | |
| 18:10-18:20 | 18:10-18:20 |
Discussion |
||